Envoy Medical Inc. (COCH)
NASDAQ: COCH
· Real-Time Price · USD
1.68
0.01 (0.90%)
At close: May 23, 2025, 3:58 PM
1.68
0.00%
After-hours: May 23, 2025, 04:23 PM EDT
0.90% (1D)
| Bid | 1.56 |
| Market Cap | 35.83M |
| Revenue (ttm) | 212K |
| Net Income (ttm) | -19.52M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -1.23 |
| Forward PE | -1.21 |
| Analyst | Strong Buy |
| Ask | 1.76 |
| Volume | 32,285 |
| Avg. Volume (20D) | 17,888 |
| Open | 1.65 |
| Previous Close | 1.67 |
| Day's Range | 1.60 - 1.68 |
| 52-Week Range | 1.21 - 3.99 |
| Beta | 2.32 |
About COCH
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COCH
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COCH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Envoy Medical Inc. is scheduled to release its earnings on May 27, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
+19.47%
Envoy Medical shares are trading higher. The compa...
Unlock content with
Pro Subscription
11 months ago
+1.75%
Envoy Medical shares are trading higher after Ascendiant Capital initiated coverage with a Buy rating and announced a price target of $8.50.
1 month ago · newsfilecorp.com
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial ResultsCompany Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear Implant Whit...
2 months ago · newsfilecorp.com
Hearing Device Coverage Clarification Act Reintroduced in House and SenateSeek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage White Bear Lake, Minnesota--(New...
